outfox

Funds / institutions · SEC Form 13F

What institutions reported holding

Search 381,214 reported position rows across 20 reporting entities and their collected quarters. Explore the holdings behind the names.

Collection dates and how to read these holdings

Partial manager coverage. Form 13F reports quarter-end holdings, usually filed later; not exact trades, transaction dates, current portfolios or ETF constituent data. Short positions, some securities, confidential holdings and unreviewed amendments may be absent. CUSIP and issuer names are preserved as filed; ticker/issuer-CIK matching is not inferred. Values use the SEC filing-date format (USD from January 3, 2023; thousands of USD before). Available valid filings are searchable even without comparison quarters. Combination reports and confidential-omission flags describe incomplete reported portfolios; only disclosed positions are shown, with no inferred missing holdings. Separate reporting entities remain separate. The latest quarter is partial as filings arrive; earlier reviewed snapshots remain searchable.

51 source-checked filings. A reported portfolio snapshot—not executed trades. Histories may be incomplete; missing data does not mean no holdings. Featured investor names identify associated management firms, not personal portfolios.

  • Third Point LLC: filed 2026-01-01–2026-10-16; collected 2026-10-18T03:14:43.118Z
  • APPALOOSA LP: filed 2026-01-01–2026-10-16; collected 2026-10-18T03:14:41.303Z
  • VANGUARD GROUP INC: filed 2026-01-01–2026-10-16; collected 2026-10-18T03:13:55.910Z
  • TWO SIGMA INVESTMENTS, LP: filed 2026-01-01–2026-10-16; collected 2026-10-18T03:14:27.467Z
  • Pershing Square Capital Management, L.P.: filed 2026-01-01–2026-10-16; collected 2026-10-18T03:14:37.679Z
  • STATE STREET CORP: filed 2026-01-01–2026-10-16; collected 2026-10-18T03:13:58.075Z
  • COATUE MANAGEMENT LLC: filed 2026-01-01–2026-10-16; collected 2026-10-18T03:14:31.488Z
  • TIGER GLOBAL MANAGEMENT LLC: filed 2026-01-01–2026-10-16; collected 2026-10-18T03:14:33.886Z
  • RENAISSANCE TECHNOLOGIES LLC: filed 2026-01-01–2026-10-16; collected 2026-10-18T03:14:25.387Z
  • GOLDMAN SACHS GROUP INC: filed 2026-01-01–2026-10-16; collected 2026-10-18T03:14:08.805Z
  • Bridgewater Associates, LP: filed 2026-01-01–2026-10-16; collected 2026-10-18T03:14:29.574Z
  • Duquesne Family Office LLC: filed 2026-01-01–2026-10-16; collected 2026-10-18T03:14:45.054Z
  • JPMORGAN CHASE & CO: filed 2026-01-01–2026-10-16; collected 2026-10-18T03:14:03.721Z
  • TCI FUND MANAGEMENT LTD: filed 2026-01-01–2026-10-16; collected 2026-10-18T03:14:46.863Z
  • PERSHING SQUARE INC.: filed 2026-01-01–2026-10-16; collected 2026-10-18T03:14:39.481Z
  • Altimeter Capital Management, LP: filed 2026-01-01–2026-10-16; collected 2026-10-18T03:14:35.674Z
  • MORGAN STANLEY: filed 2026-01-01–2026-10-16; collected 2026-10-18T03:14:12.934Z
  • FMR LLC: filed 2026-01-01–2026-10-16; collected 2026-10-18T03:14:00.998Z
  • Berkshire Hathaway Inc: filed 2026-01-01–2026-10-16; collected 2026-10-18T03:13:54.052Z
  • CITADEL ADVISORS LLC: filed 2026-01-01–2026-10-16; collected 2026-10-18T03:14:21.575Z
  • RENAISSANCE TECHNOLOGIES LLC: filed 2026-06-30–2026-11-15; collected 2026-11-16T03:25:59.260Z
  • MORGAN STANLEY: filed 2026-06-30–2026-11-15; collected 2026-11-16T03:25:53.319Z
  • STATE STREET CORP: filed 2026-06-30–2026-11-15; collected 2026-11-16T03:25:33.733Z
  • JPMORGAN CHASE & CO: filed 2026-06-30–2026-11-15; collected 2026-11-16T03:25:48.410Z

Reported positions

381,214 matching source rows · Page 665 of 15,249. A security can appear in multiple quarters or reporting entities.

IONIS PHARMACEUTICALS INC

COMMON · CUSIP 462222100

Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617

Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.

Quarter ended
2026-09-30
Filed
2026-11-12
Reported value (USD)
$8,089,810
Reported shares
167044
Source units and reporting details

Value as filed: 8089810 USD. Discretion code: DFND. Filing-local manager numbers: 4. Voting authority: sole 93514, shared 0, none 73530.

Included managers attributed to this row:

  • J.P. Morgan Investment Management Inc. · 13F file 028-11937

Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.

Original SEC submission ↗

IONIS PHARMACEUTICALS INC

COMMON · CUSIP 462222100

Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617

Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.

Quarter ended
2026-09-30
Filed
2026-11-12
Reported value (USD)
$52,131
Reported shares
1136
Source units and reporting details

Value as filed: 52131 USD. Discretion code: DFND. Filing-local manager numbers: 5. Voting authority: sole 0, shared 0, none 1136.

Included managers attributed to this row:

  • J.P. Morgan Securities LLC · 13F file 028-11925

Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.

Original SEC submission ↗

IONIS PHARMACEUTICALS INC

COMMON · CUSIP 462222100

Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617

Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.

Quarter ended
2026-09-30
Filed
2026-11-12
Reported value (USD)
$124,637
Reported shares
2716
Source units and reporting details

Value as filed: 124637 USD. Discretion code: DFND. Filing-local manager numbers: 24. Voting authority: sole 2716, shared 0, none 0.

Included managers attributed to this row:

  • J.P. Morgan SE · 13F file 028-23287

Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.

Original SEC submission ↗

IONIS PHARMACEUTICALS INC

COMMON · CUSIP 462222100

Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617

Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.

Quarter ended
2026-09-30
Filed
2026-11-12
Reported value (USD)
$161,074
Reported shares
3510
Source units and reporting details

Value as filed: 161074 USD. Discretion code: DFND. Filing-local manager numbers: 2. Voting authority: sole 211, shared 0, none 3299.

Included managers attributed to this row:

  • JPMorgan Chase Bank, N.A. · 13F file 028-00123

Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.

Original SEC submission ↗

IONIS PHARMACEUTICALS INC

COMMON · CUSIP 462222100

Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617

Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.

Quarter ended
2026-09-30
Filed
2026-11-12
Reported value (USD)
$29,853,464
Reported shares
650544
Source units and reporting details

Value as filed: 29853464 USD. Discretion code: DFND. Filing-local manager numbers: 5. Voting authority: sole 650544, shared 0, none 0.

Included managers attributed to this row:

  • J.P. Morgan Securities LLC · 13F file 028-11925

Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.

Original SEC submission ↗

IONIS PHARMACEUTICALS INC

COMMON · CUSIP 462222100

Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617

Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.

Quarter ended
2026-09-30
Filed
2026-11-12
Reported value (USD)
$6,909,474
Reported shares
150566
Source units and reporting details

Value as filed: 6909474 USD. Discretion code: DFND. Filing-local manager numbers: 8. Voting authority: sole 150566, shared 0, none 0.

Included managers attributed to this row:

  • JPMorgan Asset Management (UK) Ltd · 13F file 028-11947

Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.

Original SEC submission ↗

IONIS PHARMACEUTICALS INC

COMMON · CUSIP 462222100

Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617

Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.

Quarter ended
2026-09-30
Filed
2026-11-12
Reported value (USD)
$2,065
Reported shares
45
Source units and reporting details

Value as filed: 2065 USD. Discretion code: DFND. Filing-local manager numbers: 11. Voting authority: sole 0, shared 0, none 45.

Included managers attributed to this row:

  • J.P. Morgan Private Investments Inc. · 13F file 028-16931

Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.

Original SEC submission ↗

IONIS PHARMACEUTICALS INC

OPTION · CUSIP 462222900

Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617

Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.

Quarter ended
2026-09-30
Filed
2026-11-12
Reported value (USD)
$9,164,233
Reported shares
199700 · Call option
Source units and reporting details

Value as filed: 9164233 USD. Discretion code: DFND. Filing-local manager numbers: 5. Voting authority: sole 199700, shared 0, none 0.

Included managers attributed to this row:

  • J.P. Morgan Securities LLC · 13F file 028-11925

Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.

Original SEC submission ↗

IONIS PHARMACEUTICALS INC

OPTION · CUSIP 462222950

Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617

Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.

Quarter ended
2026-09-30
Filed
2026-11-12
Reported value (USD)
$2,023,749
Reported shares
44100 · Put option
Source units and reporting details

Value as filed: 2023749 USD. Discretion code: DFND. Filing-local manager numbers: 5. Voting authority: sole 44100, shared 0, none 0.

Included managers attributed to this row:

  • J.P. Morgan Securities LLC · 13F file 028-11925

Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.

Original SEC submission ↗

IONIS PHARMACEUTICALS INC

BOND · CUSIP 462222AF7

Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617

Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.

Quarter ended
2026-09-30
Filed
2026-11-12
Reported value (USD)
$510,052
Reported principal amount
458000
Source units and reporting details

Value as filed: 510052 USD. Discretion code: DFND. Filing-local manager numbers: 16. Voting authority: sole 458000, shared 0, none 0.

Included managers attributed to this row:

  • JPMorgan Asset Management (Japan) Ltd · 13F file 028-14958

Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.

Original SEC submission ↗

IONQ INC

COMMON · CUSIP 46222L108

Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617

Discretion: shared—other. These are reported positions, not separate purchases by each included manager.

Quarter ended
2026-09-30
Filed
2026-11-12
Reported value (USD)
$6,191
Reported shares
141
Source units and reporting details

Value as filed: 6191 USD. Discretion code: OTR. Filing-local manager numbers: 1. Voting authority: sole 0, shared 0, none 141.

Included managers attributed to this row:

  • J.P. Morgan Trust Co of Delaware · 13F file 028-12125

Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.

Original SEC submission ↗

IONQ INC

COMMON · CUSIP 46222L108

Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617

Discretion: shared—other. These are reported positions, not separate purchases by each included manager.

Quarter ended
2026-09-30
Filed
2026-11-12
Reported value (USD)
$50,990
Reported shares
1161
Source units and reporting details

Value as filed: 50990 USD. Discretion code: OTR. Filing-local manager numbers: 23. Voting authority: sole 0, shared 0, none 1161.

Included managers attributed to this row:

  • 55I, LLC · 13F file 028-19649

Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.

Original SEC submission ↗

IONQ INC

COMMON · CUSIP 46222L108

Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617

Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.

Quarter ended
2026-09-30
Filed
2026-11-12
Reported value (USD)
$2,472,967
Reported shares
56319
Source units and reporting details

Value as filed: 2472967 USD. Discretion code: DFND. Filing-local manager numbers: 5. Voting authority: sole 0, shared 0, none 56319.

Included managers attributed to this row:

  • J.P. Morgan Securities LLC · 13F file 028-11925

Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.

Original SEC submission ↗

IONQ INC

COMMON · CUSIP 46222L108

Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617

Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.

Quarter ended
2026-09-30
Filed
2026-11-12
Reported value (USD)
$10,022,897
Reported shares
206498
Source units and reporting details

Value as filed: 10022897 USD. Discretion code: DFND. Filing-local manager numbers: 4. Voting authority: sole 33372, shared 0, none 173126.

Included managers attributed to this row:

  • J.P. Morgan Investment Management Inc. · 13F file 028-11937

Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.

Original SEC submission ↗

IONQ INC

COMMON · CUSIP 46222L108

Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617

Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.

Quarter ended
2026-09-30
Filed
2026-11-12
Reported value (USD)
$905,468
Reported shares
20621
Source units and reporting details

Value as filed: 905468 USD. Discretion code: DFND. Filing-local manager numbers: 24. Voting authority: sole 20621, shared 0, none 0.

Included managers attributed to this row:

  • J.P. Morgan SE · 13F file 028-23287

Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.

Original SEC submission ↗

IONQ INC

OPTION · CUSIP 46222L908

Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617

Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.

Quarter ended
2026-09-30
Filed
2026-11-12
Reported value (USD)
$4,391
Reported shares
100 · Call option
Source units and reporting details

Value as filed: 4391 USD. Discretion code: DFND. Filing-local manager numbers: 5. Voting authority: sole 100, shared 0, none 0.

Included managers attributed to this row:

  • J.P. Morgan Securities LLC · 13F file 028-11925

Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.

Original SEC submission ↗

IOTHREE LTD

COMMON · CUSIP G4940T112

Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617

Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.

Quarter ended
2026-09-30
Filed
2026-11-12
Reported value (USD)
$21
Reported shares
10
Source units and reporting details

Value as filed: 21 USD. Discretion code: DFND. Filing-local manager numbers: 5. Voting authority: sole 10, shared 0, none 0.

Included managers attributed to this row:

  • J.P. Morgan Securities LLC · 13F file 028-11925

Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.

Original SEC submission ↗

IOVANCE BIOTHERAPEUTICS INC

COMMON · CUSIP 462260100

Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617

Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.

Quarter ended
2026-09-30
Filed
2026-11-12
Reported value (USD)
$3,440,559
Reported shares
238101
Source units and reporting details

Value as filed: 3440559 USD. Discretion code: DFND. Filing-local manager numbers: 2. Voting authority: sole 49614, shared 0, none 188487.

Included managers attributed to this row:

  • JPMorgan Chase Bank, N.A. · 13F file 028-00123

Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.

Original SEC submission ↗

IOVANCE BIOTHERAPEUTICS INC

COMMON · CUSIP 462260100

Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617

Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.

Quarter ended
2026-09-30
Filed
2026-11-12
Reported value (USD)
$86,209
Reported shares
5966
Source units and reporting details

Value as filed: 86209 USD. Discretion code: DFND. Filing-local manager numbers: 5. Voting authority: sole 0, shared 0, none 5966.

Included managers attributed to this row:

  • J.P. Morgan Securities LLC · 13F file 028-11925

Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.

Original SEC submission ↗

IOVANCE BIOTHERAPEUTICS INC

COMMON · CUSIP 462260100

Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617

Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.

Quarter ended
2026-09-30
Filed
2026-11-12
Reported value (USD)
$16,604,177
Reported shares
1149078
Source units and reporting details

Value as filed: 16604177 USD. Discretion code: DFND. Filing-local manager numbers: 4. Voting authority: sole 1022018, shared 0, none 127060.

Included managers attributed to this row:

  • J.P. Morgan Investment Management Inc. · 13F file 028-11937

Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.

Original SEC submission ↗

IOVANCE BIOTHERAPEUTICS INC

COMMON · CUSIP 462260100

Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617

Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.

Quarter ended
2026-09-30
Filed
2026-11-12
Reported value (USD)
$2,383,137
Reported shares
164923
Source units and reporting details

Value as filed: 2383137 USD. Discretion code: DFND. Filing-local manager numbers: 5. Voting authority: sole 164923, shared 0, none 0.

Included managers attributed to this row:

  • J.P. Morgan Securities LLC · 13F file 028-11925

Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.

Original SEC submission ↗

IOVANCE BIOTHERAPEUTICS INC

COMMON · CUSIP 462260100

Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617

Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.

Quarter ended
2026-09-30
Filed
2026-11-12
Reported value (USD)
$14,111,971
Reported shares
976607
Source units and reporting details

Value as filed: 14111971 USD. Discretion code: DFND. Filing-local manager numbers: 8. Voting authority: sole 976607, shared 0, none 0.

Included managers attributed to this row:

  • JPMorgan Asset Management (UK) Ltd · 13F file 028-11947

Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.

Original SEC submission ↗

IPERIONX LTD

ADR · CUSIP 44916E100

Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617

Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.

Quarter ended
2026-09-30
Filed
2026-11-12
Reported value (USD)
$76,988
Reported shares
4207
Source units and reporting details

Value as filed: 76988 USD. Discretion code: DFND. Filing-local manager numbers: 6. Voting authority: sole 4207, shared 0, none 0.

Included managers attributed to this row:

  • J.P. Morgan Securities plc · 13F file 028-12006

Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.

Original SEC submission ↗

IPERIONX LTD

ADR · CUSIP 44916E100

Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617

Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.

Quarter ended
2026-09-30
Filed
2026-11-12
Reported value (USD)
$19,288
Reported shares
1054
Source units and reporting details

Value as filed: 19288 USD. Discretion code: DFND. Filing-local manager numbers: 4. Voting authority: sole 1054, shared 0, none 0.

Included managers attributed to this row:

  • J.P. Morgan Investment Management Inc. · 13F file 028-11937

Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.

Original SEC submission ↗

IPERIONX LTD

ADR · CUSIP 44916E100

Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617

Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.

Quarter ended
2026-09-30
Filed
2026-11-12
Reported value (USD)
$92
Reported shares
5
Source units and reporting details

Value as filed: 92 USD. Discretion code: DFND. Filing-local manager numbers: 2. Voting authority: sole 5, shared 0, none 0.

Included managers attributed to this row:

  • JPMorgan Chase Bank, N.A. · 13F file 028-00123

Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.

Original SEC submission ↗